Article

Rates and Causes of Mortality Associated With Spine Surgery Based on 108,419 Procedures A Review of the Scoliosis Research Society Morbidity and Mortality Database

*Department of Neurosurgery, University of Virginia Medical Center, Charlottesville, VA †Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, MO ‡Departments of Orthopedic Surgery and Neurosurgery, University of Minnesota, Minneapolis, MN §Spine Surgery Associates, Chattanooga, TN ¶Leatherman Spine Center, Louisville, KY ‖Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA **Department of Neurosurgery, University of California San Francisco, San Francisco, CA.
Spine (Impact Factor: 2.45). 04/2012; 37(23):1975-1982. DOI: 10.1097/BRS.0b013e318257fada
Source: PubMed

ABSTRACT STUDY DESIGN.: A retrospective review of a prospectively collected database. OBJECTIVE.: To assess rates and causes of mortality associated with spine surgery. SUMMARY OF BACKGROUND DATA.: Despite the best of care, all surgical procedures have inherent risks of complications, including mortality. Defining these risks is important for patient counseling and quality improvement. METHODS.: The Scoliosis Research Society Morbidity and Mortality database was queried for spinal surgery cases complicated by death from 2004 to 2007, including pediatric (younger than 21 yr) and adult (21 yr or older) patients. Deaths occurring within 60 days and complications within 60 days of surgery that resulted in death were assessed. RESULTS.: A total of 197 mortalities were reported among 108,419 patients (1.8 deaths per 1000 patients). Based on age, rates of death per 1000 patients for adult and pediatric patients were 2.0 and 1.3, respectively. Based on primary diagnosis (available for 107,996 patients), rates of death per 1000 patients were as follows: 0.9 for degenerative (n = 47,393), 1.8 for scoliosis (n = 26,421), 0.9 for spondylolisthesis (n = 11,421), 5.7 for fracture (n = 6706), 4.4 for kyphosis (n = 3600), and 3.3 for other (n = 12,455). The most common causes of mortality included: respiratory/pulmonary causes (n = 83), cardiac causes (n = 41), sepsis (n = 35), stroke (n = 15), and intraoperative blood loss (n = 8). Death occurred prior to hospital discharge for 109 (79%) of 138 deaths for which this information was reported. The specific postoperative day (POD) of death was reported for 94 (48%) patients and included POD 0 (n = 23), POD 1-3 (n = 17), POD 4-14 (n = 30), and POD >14 (n = 24). Increased mortality rates were associated with higher American Society of Anesthesiologists score, spinal fusion, and implants (P < 0.001). Mortality rates increased with age, ranging from 0.9 per 1000 to 34.3 per 1000 for patients aged 20 to 39 years and 90 years or older, respectively. CONCLUSION.: This study provides rates and causes of mortality associated with spine surgery for a broad range of diagnoses and includes assessments for adult and pediatric patients. These findings may prove valuable for patient counseling and efforts to improve the safety of patient care.

0 Followers
 · 
88 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: : Study Design. Retrospective cohort.Objective. To identify risk factors for poor short-term outcomes after vertebral augmentation procedures.Summary of Background Data. Vertebral compression fractures are the most common fractures of osteoporosis and are frequently treated with vertebroplasty or kyphoplasty. There is a shortage of information about risk factors for short-term, general health outcomes after vertebral augmentation in the literature.Methods. Patients aged 65 and over who underwent vertebroplasty or kyphoplasty in 2011 and 2012 were identified from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. Patient characteristics were tested for association with 30-day adverse events, mortality, and readmission using bivariate and multivariate analyses.Results. A total of 850 patients met inclusion criteria. The average age was 78.9 ± 11.7 years (mean ± standard deviation) and the cohort was 70.8% female. Of these patients, 9.5% had any adverse event (AAE), and 6.6% had a severe adverse event (SAE). Death occurred in 1.5% of patients, and 10.8% were readmitted within the first 30 postoperative days.On multivariate analysis, AAE and SAE were both significantly associated with American Society of Anesthesiologists (ASA) class 4 (AAE: odds ratio [OR] = 2.7, p = 0.013; SAE: OR = 2.5, p = 0.040) and inpatient status before procedure (AAE: OR = 2.7, p <0.001, SAE: OR = 2.4, p = 0.003). Increased postoperative mortality was associated with ASA class 4 (OR = 6.4, p = 0.024) and the use of non-general anesthesia (OR = 4.0, p = 0.022). Readmission was associated with history of pulmonary disease (OR = 2.0, p = 0.005) and inpatient status before procedure (OR = 1.9, p = 0.005).Conclusions. Adverse general health outcomes were relatively common, and the above-identified factors associated with patient outcomes after vertebral augmentation may be useful for preoperative discussions and counseling.
    Spine 08/2014; 39(23). DOI:10.1097/BRS.0000000000000563 · 2.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Study Design. Retrospective case control study.Objective. To evaluate the hemostatic benefits of using a kaolin impregnated dressing during pediatric spinal deformity correction surgery.Summary of Background Data. Minimizing blood loss and transfusions are clear benefits for patient safety. A technique common in both severe trauma and combat medicine that has not been reported in the spine literature is wound packing with a kaolin impregnated haemostatic dressing.Methods. Estimated blood loss and transfusion amounts were analyzed in a total of 117 retrospectively identified cases. The control group included 65 patients (46F, 19M, 12.7±4.5 years, 10.2± 4.8 levels fused) who received standard operative care with gauze packing between June 2007 and March 2010. The treatment group included 52 patients (33F, 19M, 13.9±3.2 years, 10.4 ± 4.3 levels fused) who underwent intra-operative packing with QuikClot Trauma Pads (QCTP, Z-Medica Corporation) for all surgeries from July 2010 to August 2011. No other major changes in the use of antifibrinolytics or perioperative, surgical, or anesthesia technique were noted. Statistical differences were analyzed using ANCOVA in R with p<0.05. The statistical model included sex, age, weight, scoliosis type, the number of vertebral levels fused, and surgery duration as covariates.Results. The treatment group had 40% less intra-operative estimated blood loss than the control group (974 cc vs 1620 cc) (p<0.001). Patients who received the QCTP treatment also had 42% less total perioperative transfusion volume (499 cc vs 862 cc) (p<0.01).Conclusion. The use of a kaolin impregnated intra-operative trauma pad appears to be an effective and inexpensive method to reduce intra-operative blood loss and transfusion volume in pediatric spinal deformity surgery.
    Spine 06/2014; 39(19). DOI:10.1097/BRS.0000000000000466 · 2.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Study Design. Multi-center, prospective analysis of consecutive ASD patients.Objective. Evaluate complications associated with rhBMP-2 use in ASDSummary of Background Data. Off-label rhBMP-2 use is common, however under-reporting of rhBMP-2 associated complications has been recently scrutinized.Methods. ASD patients consecutively enrolled into a prospective, multicenter database, were evaluated for type and timing of acute perioperative complications. Inclusion criteria: age ≥ 18 years, ASD, spinal arthrodesis >4 levels, and ≥3 months follow-up. Patients divided into those receiving rhBMP-2 (BMP) or no rhBMP-2 (NOBMP). BMP divided into location of use: posterior (PBMP), interbody (IBMP), and interbody + posterior spine (I+PBMP). Correlations between acute perioperative complications and rhBMP-2 use including total dose, dose/level and location of use were evaluated.Results. 279 patients (mean age 57 years, mean spinal levels fused 12.0, mean follow-up 28.8 months) met inclusion criteria. BMP (n = 172; average posterior dose = 2.5 mg/level, average interbody dose = 5 mg/level) had similar age, smoking history, previous spine surgery, total spinal levels fused, estimated blood loss, and duration of hospital stay as NOBMP (n = 107; p>0.05). BMP had greater Charlson Comorbidity Index (1.9 vs. 1.2), greater scoliosis (43° vs. 38°), longer operative time (488.2 vs. 414.6 minutes), more osteotomies/patient (4.0 vs. 1.6) and greater percentage of anteroposterior fusion (APSF; 20.9% vs. 8.4%) than NOBMP, respectively (p<0.05). BMP had more total complications/patient (1.4 vs.0.6) and more minor complications/patient (0.9 vs. 0.2) than NOBMP, respectively (p<0.05). NOBMP had more complications requiring surgery/patient than BMP (0.3 vs. 0.2; p<0.05). Major, neurological, wound, and infection complications were similar for NOBMP, BMP, PBMP, IBMP, and I+PBMP (p>0.05). Multivariate analysis demonstrated small to non-existent correlations between rhBMP-2 use and complications.Conclusions. RhBMP-2 use and location of rhBMP-2 use in ASD surgery, at reported doses, does not increase acute major, neurological or wound complications. Research is needed for higher rhBMP-2 dosing and long-term follow-up.
    Spine 11/2013; DOI:10.1097/BRS.0000000000000104 · 2.45 Impact Factor

Full-text

Download
13 Downloads
Available from
May 21, 2014